Coronary stenting is the most commonly used method of myocardial revascularization, with approximately 2 million stents implanted in 2004 throughout the world. The development of drug eluting stents has resulted in very low rates of repeat intervention and will further increase the scope for percutaneous coronary intervention.
The evidence from large randomized trials is generally accepted to be the gold standard source of information for patient care in interventional cardiology. However, it is well recognized that information from these trials is frequently insufficient to guide the wide-ranging clinical situations found in routine practice. In this context, decision-making is often based on a composite of information from multiple clinical studies, pathophysiological considerations and importantly, personal experience or 'gut-feeling'.
This book, written by internationally recognized experts in their field, provides clear and concise recommendations regarding various challenging clinical situations facing the interventional cardiologist on a daily basis.
Table of Contents
Immunoallergic Syndromes in Interventional Cardiology. The Kidney in Percutaneous Coronary Intervention. Ad Hoc Percutaneous Coronary Intervention - Merits and Disadvantages. Advanced Atherosclerotic Disease in Multiple Vascular Bed Sites. The Intermediate / Non-stenotic Coronary lesion. Acute Myocardial Infarction Complicated by Cardiogenic Shock. The Hypotensive Patient After Angioplasty: Occult Life-threatening PCI-related Complications. Percutaneous Treatment for Patients with End-stage Aortic Valve Stenosis. Acute Coronary Dissection, Occlusion, and Perfuration During PCI. Surgical, Percutaneous, or Medical Management. Role of Interventional Cardiology in Functional Coronary Stenosis. Drug-Eluting Stent Complications - DES Thrombosis and Restenosis. Coronary Intervention in Patients with Anti-Platelet Therapy Resistance
Eulógio E Martinez, Pedro A Lemos, Andrew TL Ong, Patrick W Serruys